Compounds > 2-(4-morpholinoanilino)-6-cyclohexylaminopurine
Page last updated: 2024-09-05

2-(4-morpholinoanilino)-6-cyclohexylaminopurine and sq-23377

2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with sq-23377 in 1 studies

Compound Research Comparison

Studies
(2-(4-morpholinoanilino)-6-cyclohexylaminopurine)		Trials
(2-(4-morpholinoanilino)-6-cyclohexylaminopurine)		Recent Studies (post-2010)
(2-(4-morpholinoanilino)-6-cyclohexylaminopurine)		Studies
(sq-23377)		Trials
(sq-23377)		Recent Studies (post-2010) (sq-23377)
850624,38510493

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fezai, M; Jemaà, M; Lang, F1

Other Studies

1 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and sq-23377

ArticleYear
Inhibition of Suicidal Erythrocyte Death by Reversine.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 41, Issue:6

    Topics: Cells, Cultured; Energy Metabolism; Eryptosis; Erythrocyte Membrane; Erythrocytes; Humans; Ionomycin; Morpholines; Oxidative Stress; Phosphatidylserines; Purines; tert-Butylhydroperoxide

2017